Successfully executing the complex conversion of production plants

COVID-19 vaccine: A race against time

Many pharmaceutical and biotech companies are currently working on the production of Corona virus vaccines. Pressure to get this done quickly is enormous: many people are still infected, the global economy is suffering and hundreds of thousands of people have lost loved ones. Although vaccinations have already begun in many countries, it will take time to produce a sufficient number of vaccine doses for everyone who needs one.

Given the shortage of vaccine, what is needed now more than anything else is greater speed in production. Bilfinger helped a pharmaceutical company quickly convert its plant for the industrial production of Corona vaccines.

As a long-standing partner of the pharmaceutical industry, we are proud to contribute to the fight against the Corona pandemic with this project.

Christian Gebetsberger, Managing Director/Head of Operations at Bilfinger Industrietechnik Salzburg GmbH

Fast deployment and assembly under tight deadlines

In a short period of time and under tremendous pressure, the Bilfinger team delivered and installed systems, valves and piping for the conversion of a plant for a well-known customer in the pharmaceutical industry. The equipment had previously been used to manufacture other biotech industry products.

“As a long-standing partner of the pharmaceutical industry, we are proud to contribute to the fight against the Corona pandemic with this project,” says Christian Gebetsberger, Managing Director/Head of Operations at Bilfinger Industrietechnik Salzburg GmbH. “Thanks to our experienced team and a resilient network of suppliers, we were able to provide and assemble the required plant components at very short notice. This was critical to the success of the complex conversion – because time is the decisive factor in vaccine production.”

The team from Austrian subsidiary Bilfinger Industrietechnik Salzburg delivered and installed equipment, valves and piping. Various media required for vaccine production will flow through these pipes. Bilfinger won the order at very short notice and performed the work within just a few months.

The biggest challenge was to quickly purchase the required parts in a very short period of time, get them on site and assemble them. Due to the extreme time pressure, planning and construction were carried out simultaneously on the construction site.

Expertise in plant engineering

Bilfinger assumes responsibility for the design, manufacture and assembly of process units and plants for the biotechnology and pharmaceutical sectors in countries all over the world. The range of services covers the entire lifecycle of a plant.

We provide project management, engineering, process technology as well as qualification and offer piping construction as well as tank and apparatus engineering, E/I&C (electrical, instrumentation and control), automation and much more.

Contact in case of questions:

Christian Gebetsberger
Managing Director/Head of Operations at Bilfinger Industrietechnik Salzburg GmbH
Phone +43 662 8695-240
E-Mail

 

 

Print